Sarah Clifford
Consultant Infectious Disease Physician
Position:
Consultant Infectious Disease Physician
Research Interests:
Imported infections
Asylum Seeker
Refugee Health Parasitology
Projects/Grants:
GeoSentinel
Background:
Consultant in Infectious Diseases and Acute medicine appointed in 2024. Established a clinic focussing on the health of Asylum seekers and Refugees new to Scotland. I undertook a MSc in Molecular Biology of Parasites and Disease Vectors followed by the Diploma in Tropical Medicine and Hygiene at the Liverpool School of Tropical Medicine, and training in clinical tropical medicine in Peru (The Gorgas Course).
Key Publications
2024
Noble R, Clifford S, Duguid A. Circulating plasmablasts in dengue fever. EJHaem. 2024 Sep 26;5(5):1080-1081.
2018
Betson M, Clifford S, Stanton M, Kabatereine NB, Stothard JR. Emergence of Nonfalciparum Plasmodium Infection Despite Regular Artemisinin Combination Therapy in an 18-Month Longitudinal Study of Ugandan Children and Their Mothers. J Infect Dis. 2018 Mar 13;217(7):1099-1109.
2015
Lewis JM, Clifford S, Nsutebu E. Toxoplasmosis in immunosuppressed patients. Rheumatology (Oxford). 2015 Nov;54(11):1939-40.
2012
Betson M, Sousa-Figueiredo JC, Clifford S, Atuhaire A, Arinaitwe M, Adriko M, Mwesigwa G, Nabonge J, Kabatereine NB, Sutherland CJ, Stothard JR. Artemther-lumefantrine is partially effective for treating chronic multi-species malaria in Ugandan pre-school children. Malar J. 2012 Oct 15;11(Suppl 1):P11.
All Publications
2024
Noble R, Clifford S, Duguid A. Circulating plasmablasts in dengue fever. EJHaem. 2024 Sep 26;5(5):1080-1081.
2023
Pascall DJ, Vink E, Blacow R, Bulteel N, Campbell A, Campbell R, Clifford S, Davis C, da Silva Filipe A, El Sakka N, Fjodorova L, Forrest R, Goldstein E, Gunson R, Haughney J, Holden MTG, Honour P, Hughes J, James E, Lewis T, Lycett S, MacLean O, McHugh M, Mollett G, Onishi Y, Parcell B, Ray S, Robertson DL, Shabaan S, Shepherd JG, Smollett K, Templeton K, Wastnedge E, Wilkie C, Williams T, Thomson EC; COVID-19 Genomics UK (COG-UK) Consortium. The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis. PLoS One. 2023 Apr 13;18(4):e0284187.
Pascall DJ, Vink E, Blacow R, Bulteel N, Campbell A, Campbell R, Clifford S, Davis C, da Silva Filipe A, El Sakka N, Fjodorova L, Forrest R, Goldstein E, Gunson R, Haughney J, Holden MTG, Honour P, Hughes J, James E, Lewis T, MacLean O, McHugh M, Mollett G, Nyberg T, Onishi Y, Parcell B, Ray S, Robertson DL, Seaman SR, Shabaan S, Shepherd JG, Smollett K, Templeton K, Wastnedge E, Wilkie C, Williams T; COVID-19 Genomics UK (COG-UK) Consortium; Thomson EC. Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent. J Infect. 2023 Aug;87(2):128-135.
2022
RECOVERY Collaborative Group. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2022 Jan 8;399(10320):143-151.
RECOVERY Collaborative Group. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2022 Feb 12;399(10325):665-676.
Dolby HW, Clifford SA, Laurenson IF, Fowler VG, Russell CD. Heterogeneity in Staphylococcus aureus Bacteraemia Clinical Trials Complicates Interpretation of Findings. J Infect Dis. 2022 Sep 4;226(4):723-728.
RECOVERY Collaborative Group. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet. 2022 Jul 30;400(10349):359-368. doi: 10.1016/S0140-6736(22)01109-6. Erratum in: Lancet. 2022 Oct 1;400(10358):1102.
2021
RECOVERY Collaborative Group. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021 Feb 13;397(10274):605-612.
RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021 May 1;397(10285):1637-1645.
RECOVERY Collaborative Group. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet. 2021 May 29;397(10289):2049-2059.
2020
Hill KJ, Russell CD, Clifford S, Templeton K, Mackintosh CL, Koch O, Sutherland RK. The index case of SARS-CoV-2 in Scotland. J Infect. 2020 Jul;81(1):147-178.
Li L, Ross D, Hill K, Clifford S, Wellington L, Sumpter C, Gadsby NJ, Crane J, Macsween KF, Hopkins KL, Fry NK, Koch O, Stevenson J. Two cases of imported respiratory diphtheria in Edinburgh, Scotland, October 2019. Epidemiol Infect. 2020 May 15;148:e143.
McLeod A, Hutchinson SJ, Smith S, Leen C, Clifford S, McAuley A, Wallace LA, Barclay ST, Bramley P, Dillon JF, Fraser A, Gunson RN, Hayes PC, Kennedy N, Peters E, Templeton K, Goldberg DJ. Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study. HIV Med. 2021 May;22(5):334-345.
Clifford S, Cevik M, Campbell R, O’Shea D, Sutherland R. Expect the unexpected – Implications for next phase of COVID-19 response. Infect Prev Pract. 2021 Jun;3(2):100118.
2018
Betson M, Clifford S, Stanton M, Kabatereine NB, Stothard JR. Emergence of Nonfalciparum Plasmodium Infection Despite Regular Artemisinin Combination Therapy in an 18-Month Longitudinal Study of Ugandan Children and Their Mothers. J Infect Dis. 2018 Mar 13;217(7):1099-1109.
Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, Longenecker CT, Strachan F, Bagchi S, Whiteley W, Rajagopalan S, Kottilil S, Nair H, Newby DE, McAllister DA, Mills NL. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis. Circulation. 2018 Sep 11;138(11):1100-1112.
2018
Betson M, Clifford S, Stanton M, Kabatereine NB, Stothard JR. Emergence of Nonfalciparum Plasmodium Infection Despite Regular Artemisinin Combination Therapy in an 18-Month Longitudinal Study of Ugandan Children and Their Mothers. J Infect Dis. 2018 Mar 13;217(7):1099-1109.
2015
Lewis JM, Clifford S, Nsutebu E. Toxoplasmosis in immunosuppressed patients. Rheumatology (Oxford). 2015 Nov;54(11):1939-40.
2012
Betson M, Sousa-Figueiredo JC, Clifford S, Atuhaire A, Arinaitwe M, Adriko M, Mwesigwa G, Nabonge J, Kabatereine NB, Sutherland CJ, Stothard JR. Artemther-lumefantrine is partially effective for treating chronic multi-species malaria in Ugandan pre-school children. Malar J. 2012 Oct 15;11(Suppl 1):P11.
